490. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1276 of 26 May 2026 if the national treatment abroad office in Kilkenny is the sole point of approval for all treatment abroad scheme applications; and the circumstances under which an application is approved, reviewed, or processed outside the Kilkenny office. [50561/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn under the heading Departmental Schemes.
146 questions match, newest first.
491. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1276 of 26 May 2026 to confirm whether the HSE maintains a written procedure, circular, or delegated authority schedule setting out which staff grade or management level is authorised to approve treatment abroad scheme applications; and if no such written procedure exists, the basis on which approval authority is exercised. [5…
492. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 267 of 27 May 2026 to provide a response concerning whether an approval rate benchmarking exists between specialties, consultants, or regions under the treatment abroad scheme, noting that the previous response addressed an unrelated question on the age profile of overseas gender affirmation surgery approvals rather than the q…
502. Deputy Ken O'Flynn asked the Minister for Health to provide the specific euro threshold or thresholds above which Grade VII approval no longer applies to treatment abroad scheme applications; the grade or officeholder responsible for authorising applications above each such threshold; and the nature of the "applicable derogations" referenced in the Health Service Executive's reply of 19th June 2026. [50582/26]
505. Deputy Ken O'Flynn asked the Minister for Health given that individual figures may be withheld on confidentiality grounds, to provide the highest individual expenditure approved under the treatment abroad scheme in each year since 2020 in banded form (for example, within ranges of €50,000); and to confirm whether any approved application since 2020 exceeded €500,000. [50585/26]
506. Deputy Ken O'Flynn asked the Minister for Health to confirm directly whether the Comptroller and Auditor General has examined the treatment abroad scheme specifically at any point since 2020; to provide the date of any such examination; and to confirm whether any external, non-HSE body has conducted a value-for-money or governance review of the scheme since 2020. [50586/26]
507. Deputy Ken O'Flynn asked the Minister for Health to confirm directly whether the absence of publicly available approval thresholds within the treatment abroad scheme appears on the Health Service Executive's corporate risk register; and if it does not, to confirm this directly rather than by general reference to oversight arrangements. [50587/26]
508. Deputy Ken O'Flynn asked the Minister for Health further Parliamentary Question No. 581 of 14 June 2026, in which the Health Service Executive did not address the substantive matter raised, to confirm whether the treatment abroad scheme dataset records the age of patients approved for funding of overseas gender affirmation surgeries; if this data is not currently captured, to state the reason; and if her Departm…
509. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1116 of 19 May 2026, in which expenditure figures were provided for treatment costs and travel costs only, to confirm whether the figures published include accommodation, administration, translation, or assessment costs; if so, to provide a separate costed breakdown of each category for the years 2020 to 2025; the way in which…
2058. Deputy Ken O'Flynn asked the Minister for Health whether the absence of any national clinical audit relating to procedures funded under the Treatment Abroad Scheme since 2020 is considered acceptable from a patient-safety and governance perspective; and if she will make a statement on the matter. [42505/26]
2059. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE has conducted any risk assessment regarding the absence of national clinical outcome auditing for procedures funded under the treatment abroad scheme; and if she will make a statement on the matter. [42506/26]
2060. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any mechanism to systematically monitor complication rates, revision procedures, adverse outcomes, readmissions, or long-term follow-up care requirements arising from procedures funded under the Treatment Abroad Scheme; and if she will make a statement on the matter. [42507/26]
2061. Deputy Ken O'Flynn asked the Minister for Health whether any national framework exists governing post-treatment outcome monitoring for patients returning to Ireland following procedures funded under the Treatment Abroad Scheme; and if she will make a statement on the matter. [42508/26]
2062. Deputy Ken O'Flynn asked the Minister for Health whether the HSE National Centre for Clinical Audit has ever been requested by her Department, the HSE, or the Treatment Abroad Scheme to consider conducting a national clinical audit relating to procedures funded under the Treatment Abroad Scheme; and if she will make a statement on the matter. [42509/26]
2063. Deputy Ken O'Flynn asked the Minister for Health whether any official within her Department or the HSE holds responsibility for assessing whether procedures funded under the Treatment Abroad Scheme should be subject to national clinical audit or outcome monitoring; and if she will make a statement on the matter. [42510/26]
605. Deputy Ken O'Flynn asked the Minister for Education and Youth whether her Department will review the adequacy of iScoil funding in light of the fact that 381 eligible referrals were refused places since the 2022-2023 academic year due to limited capacity; and if she will make a statement on the matter. [39734/26]
606. Deputy Ken O'Flynn asked the Minister for Education and Youth whether her Department will establish a target that no eligible child referred to iScoil should be refused a place solely due to funding or capacity limitations; and if she will make a statement on the matter. [39735/26]
607. Deputy Ken O'Flynn asked the Minister for Education and Youth whether any assessment has been carried out into the long-term educational outcomes for children who were eligible for iScoil but were refused a place due to capacity limitations; and if she will make a statement on the matter. [39736/26]
1242. Deputy Ken O'Flynn asked the Minister for Health whether any expenditure threshold exists within the treatment abroad scheme above which additional managerial, financial, legal or executive approval is required prior to authorisation of treatment abroad. [39141/26]
1243. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme operates any formal distinction between clinical eligibility approval and financial expenditure approval; and if so, to provide details of the separate approval pathway. [39136/26]
1244. Deputy Ken O'Flynn asked the Minister for Health the grade, title or officeholder responsible for final authorisation of individual treatment abroad scheme applications involving projected expenditure above €100,000. [39137/26]
1245. Deputy Ken O'Flynn asked the Minister for Health whether any internal audit, value-for-money review or external governance review of high-cost treatment abroad scheme approvals has been conducted since 2020; and if so, to provide details and findings. [39138/26]
1246. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a register of the highest-cost treatments approved annually under the treatment abroad scheme and the aggregate annual expenditure associated with such approvals. [39139/26]
1247. Deputy Ken O'Flynn asked the Minister for Health whether her Department receives routine reporting on high-cost approvals under the treatment abroad scheme, including cumulative expenditure, approval volumes and exceptional-case expenditure. [39140/26]
1248. Deputy Ken O'Flynn asked the Minister for Health whether the 2022 Comptroller and Auditor General audit referenced in relation to the treatment abroad scheme constituted a full scheme audit or a sample-based review; and if she will provide the scope, methodology and findings of same. [39135/26]